21-hydroxylase deficiency laboratory findings: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. {{Congenital adrenal hyperplasia due ...") |
No edit summary |
||
| Line 14: | Line 14: | ||
===Childhood onset (simple virilizing) CAH=== | ===Childhood onset (simple virilizing) CAH=== | ||
A diagnosis of SVCAH is usually confirmed by discovering extreme elevations of [[17-hydroxyprogesterone]] along with moderately high testosterone levels. A [[ACTH|cosyntropin]] stimulation test may be needed in mild cases, but usually the random levels of 17OHP are high enough to confirm the diagnosis. | * A diagnosis of SVCAH is usually confirmed by discovering extreme elevations of [[17-hydroxyprogesterone]] along with moderately high testosterone levels. A [[ACTH|cosyntropin]] stimulation test may be needed in mild cases, but usually the random levels of 17OHP are high enough to confirm the diagnosis. | ||
===Late onset (nonclassical) CAH=== | ===Late onset (nonclassical) CAH=== | ||
Diagnosis of late-onset CAH may be suspected from a high 17-hydroxyprogesterone level, but some cases are so mild that the elevation is only demonstrable after cosyntropin stimulation. | * Diagnosis of late-onset CAH may be suspected from a high 17-hydroxyprogesterone level, but some cases are so mild that the elevation is only demonstrable after cosyntropin stimulation. | ||
==References== | ==References== | ||
Revision as of 15:51, 20 September 2012
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
|
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
21-hydroxylase deficiency laboratory findings On the Web |
|
American Roentgen Ray Society Images of 21-hydroxylase deficiency laboratory findings |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
|
Risk calculators and risk factors for 21-hydroxylase deficiency laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Laboratory Findings
Salt-wasting crises in infancy
- Basic chemistries will reveal hyponatremia, with a serum Na+ typically between 105 and 125 mEq/L. Hyperkalemia in these infants can be extreme—levels of K+ above 10 mEq/L are not unusual—as can the degree of metabolic acidosis. Hypoglycemia may be present. This is termed a salt-wasting crisis and rapidly causes death if not treated.
Childhood onset (simple virilizing) CAH
- A diagnosis of SVCAH is usually confirmed by discovering extreme elevations of 17-hydroxyprogesterone along with moderately high testosterone levels. A cosyntropin stimulation test may be needed in mild cases, but usually the random levels of 17OHP are high enough to confirm the diagnosis.
Late onset (nonclassical) CAH
- Diagnosis of late-onset CAH may be suspected from a high 17-hydroxyprogesterone level, but some cases are so mild that the elevation is only demonstrable after cosyntropin stimulation.